Co-delivery of endoplasmic reticulum-targeted photosensitizer and Ido-1 inhibitor potentiates immunotherapeutic efficacy in triple-negative breast cancer
{{output}}
Triple-negative breast cancer (TNBC) generally has a poor response to immunotherapy due to low immunogenicity and an immunosuppressive tumor microenvironment. To address this, a multifunctional nanoparticle, TPI@RPB, was constructed with RGD-PEG-BSA as the car... ...
